论文信息 - High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II study. - 字舞流文

High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II study.

E. de Vries | D. Sleijfer | N. Mulder | A. Maas | P. Postmus | P. O. Mulder | H. G. de Vries-Hospers | A. Meinesz